5-FU cream found to reduce the risk of squamous cell carcinoma
Clinical trial results provide evidence that using the generic skin cream fluorouacil 5 percent for two to four weeks may reduce the risk of SCC...
List view / Grid view
News
Removable implant may control type 1 diabetes
Researchers have devised a method for implanting islet cells into a patient that may control the management of type 1 diabetes...
Kisqali receives breakthrough therapy designation for advanced breast cancer
Kisqali receives breakthrough therapy designation for initial endocrine-based treatment of pre- or perimenopausal women with HR+/HER2- advanced or metastatic breast cancer...
Precision NanoSystems named as one of British Columbia’s fastest growing companies
Precision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published Top 100 fastest-growing companies in BC list from business news journal Business in Vancouver (BIV)...
Silver nanoparticles improve molecular detection in Raman spectroscopy
Researchers have improved molecular detection at low concentration levels by arranging nanoparticles on nanowires to enhance Raman spectroscopy....
Diabetes drug significantly reverses memory loss in Alzheimer’s disease
A drug developed for diabetes could be used to treat Alzheimer's after scientists discover it significantly reversed memory loss in mice through a triple method of action...
Seasonal images reflect stem cells science
University of Southampton postgraduate researcher Catarina Moura creates seasonal images from stem cells as part of her investigation into new optical techniques to monitor the cells' development.
NICE recommends routine access to beta interferon drug for MS
Multiple sclerosis patients to have routine access to beta interferon drug, says NICE in new draft guidance.
Clinical trial transparency reaches record level
Disclosure rate of industry-sponsored clinical trials at 12 months has significantly improved year on year from 71% in 2009 to 93% in 2014, according to ABPI-sponsored study.
Heroin vaccine could tackle opioid addiction
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
FDA approves Nucala for Eosinophilic Granulomatosis with Polyangiitis
The FDA has expanded the approved use of Nucala to treat a rare autoimmune disease that causes vasculitis, an inflammation of the wall of blood vessels of the body...
Joint policy document shows the potential impact of Brexit
The associations representing the European and British life science industry have launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union...
UK and Russian researchers join forces against AMR
Two of the key organisations in the UK and Russia leading efforts to combat the global problem of antimicrobial resistance (AMR) have announced a formal agreement to work together.
Plasmonic biosensors enable development of new easy-to-use health tests
Researchers have developed a biosensor that can detect diseased exosomes, important indicators of various health conditions...
3-D printed microfibers could provide structure for artificially grown body parts
Researchers believe they have a way to create the structural framework for growing living tissue using an off-the-shelf 3-D printer...
